| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |